BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $480,000 | +686.9% | 75,631 | +414.5% | 0.00% | +300.0% |
| Q2 2022 | $61,000 | -93.9% | 14,700 | -92.8% | 0.00% | -88.9% |
| Q1 2022 | $993,000 | +794.6% | 204,700 | +1744.1% | 0.01% | +800.0% |
| Q4 2021 | $111,000 | -83.9% | 11,100 | -48.6% | 0.00% | -85.7% |
| Q2 2021 | $691,000 | +222.9% | 21,605 | +204.3% | 0.01% | +133.3% |
| Q1 2021 | $214,000 | -40.1% | 7,101 | +7.3% | 0.00% | -57.1% |
| Q3 2020 | $357,000 | +10.2% | 6,616 | -6.2% | 0.01% | -65.0% |
| Q1 2020 | $324,000 | -75.6% | 7,057 | -53.3% | 0.02% | -37.5% |
| Q4 2019 | $1,326,000 | -35.0% | 15,109 | +16.2% | 0.03% | -71.2% |
| Q2 2018 | $2,041,000 | +63.7% | 13,000 | -54.9% | 0.11% | -60.2% |
| Q2 2016 | $1,247,000 | +237.0% | 28,812 | +231.4% | 0.28% | +84.8% |
| Q1 2016 | $370,000 | – | 8,695 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |